使用纳米载体进行纳米封装和生物活性成分的输送:方法,表征,应用和观点
1Department of Food Science and Human Nutrition, University of Illinois at Urbana-Champaign, Urbana, IL 61801 USA.
Food science and biotechnology
|March 5, 2024
概括
蛋白是一种有前途的生物材料,用于制造生物活性成分的纳米载体. 本综述详细介绍了各种行业中基于基的纳米封装的方法,应用和未来方向.
科学领域:
- 材料科学 材料科学 材料科学
- 生物技术是生物技术.
- 食品科学 食品科学 食品科学
背景情况:
- 齐宁蛋白质表现出极好的自我组装,两性和生物相容性.
- 这些特性使其成为开发纳米尺寸输送系统的多功能材料.
研究的目的:
- 审查目前使用基于 zein 的纳米载体进行纳米封装和传递生物活性成分的策略.
- 讨论这些系统的表征,稳定性和应用.
主要方法:
- 对各种基于晶体的纳米载体结构 (纳米粒子,纳米纤维,纳米乳液,纳米凝) 的审查.
- 分析影响纳米载体稳定性的因素.
- 生物活性载荷和纳米载体的表征技术的总结.
主要成果:
- 详细讨论生物活性成分的各种纳米封装策略.
- 突出了纳米载体稳定性和表征的关键因素.
- 目前在食品,制药,化品和农业领域的应用概述.
结论:
- 基于Zin的纳米载体为生物活性成分的输送提供了一个强大的平台.
- 本综述作为选择合适的纳米封装技术和了解其应用的指南.
相关概念视频
Drug Delivery: Overview
1.3K
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
1.3K
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
361
Bioavailability is a critical pharmacological concept that measures the extent and rate at which an active drug ingredient or therapeutic moiety enters the systemic circulation, remaining unchanged. It's a pivotal factor in determining a drug's efficacy and safety.The Biopharmaceutics Classification System (BCS) plays an essential role in drug development by categorizing drugs into four classes based on their solubility and permeability. This classification aids in understanding drug absorption...
361
Bioavailability Enhancement: Drug Solubility Enhancement
505
Bioavailability is a critical factor in determining a drug's effectiveness. It refers to the proportion of a drug that enters the circulation when introduced into the body and is, as a result, able to have an active effect. Enhancing bioavailability is essential for drugs with poor solubility, as it can significantly impact their therapeutic efficacy. Various methods are employed to increase the solubility of drugs, thereby enhancing their bioavailability.Micronization and nanonization are...
505
Bioavailability Enhancement: Drug Permeability Enhancement
360
After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...
360
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
336
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
336
Site-Targeted Drug Delivery Systems: Polymeric Carriers
167
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
167


